Cargando…

Therapeutic Drug Level Monitoring of Teicoplanin in Korean Pediatric Patients with Normal versus Impaired Renal Function

BACKGROUND: Teicoplanin is used to treat serious gram-positive infections. Optimal teicoplanin trough levels are considered to be ≥ 10 μg/mL. Despite its wide use in various clinical settings, data on teicoplanin trough level in pediatric patients are limited. Therefore, the aim of this study was to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Joon-sik, Kim, Jong Min, Kim, Dongsub, Kim, Si-Ho, Cho, Heeyeon, Park, Hyung-Doo, Lee, Soo-Youn, Kang, Cheol-In, Kim, Yae-Jean
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7707924/ https://www.ncbi.nlm.nih.gov/pubmed/33258328 http://dx.doi.org/10.3346/jkms.2020.35.e376

Ejemplares similares

Optimal Use and Need for Therapeutic Drug Monitoring of Teicoplanin in Children: A Systematic Review
por: Choi, Joon-sik, et al.
Publicado: (2023)

Is Therapeutic Drug Monitoring of Teicoplanin Useful?
por: Kim, Shin-Woo
Publicado: (2014)

Teicoplanin Dosing Strategy for Treatment of Staphylococcus aureus in Korean Patients with Neutropenic Fever
por: Ahn, Byung-Jin, et al.
Publicado: (2011)

Therapeutic Drug Concentrations of Teicoplanin in Clinical Settings
por: Nah, So-Yun, et al.
Publicado: (2014)

COVID-19 Vaccination Status Among Korean Pediatric Population With Comorbidities
por: Shin, Areum, et al.
Publicado: (2023)

Arbekacin as an Alternative Drug to Teicoplanin for the Treatment of MRSA Infection
por: Hwang, Ji-Hee, et al.
Publicado: (2016)

A Case of Hypersensitivity Syndrome to Both Vancomycin and Teicoplanin
por: Kwon, Hyouk-Soo, et al.
Publicado: (2006)

Monitoring Thiopurine Metabolites in Korean Pediatric Patients with Inflammatory Bowel Disease
por: Kim, Mi Jin, et al.
Publicado: (2014)

581. The Epidemiology of Imipenem-Resistant Acinetobacter baumannii Bacteremia in a Pediatric Intensive Care Unit and Carbapenem Use
por: Kim, Dongsub, et al.
Publicado: (2019)

1697. Comparison of Candidemia in Patients in Neonatal Intensive Care Unit and Pediatric Patients and Big Data Analysis on Candidiasis and Candidemia in Korean Children
por: Choi, Joon-sik, et al.
Publicado: (2019)

Comparison of mortality and clinical failure rates between vancomycin and teicoplanin in patients with methicillin-resistant Staphylococcus aureus pneumonia
por: Lee, Jang Ho, et al.
Publicado: (2022)

Accuracy of Therapeutic Drug Monitoring of Teicoplanin at the Onset of Febrile Neutropenia
por: Takigawa, Masaki, et al.
Publicado: (2023)

The Changes in Epidemiology of Imipenem-Resistant Acinetobacter baumannii Bacteremia in a Pediatric Intensive Care Unit for 17 Years
por: Kim, Dongsub, et al.
Publicado: (2022)

Myositis as an Initial Presentation of Ulcerative Colitis before Gastrointestinal Symptoms
por: Kim, Doo Ri, et al.
Publicado: (2020)

Recommended immunization schedule for children and adolescents: the Korean Pediatric Society, 2013
por: Jo, Dae Sun, et al.
Publicado: (2013)

Population Pharmacokinetics and Model-Based Dosing Optimization of Teicoplanin in Pediatric Patients
por: Zhang, Tao, et al.
Publicado: (2020)

Scabies mimicking graft versus host disease in a hematopoietic cell transplant recipient
por: Kim, Dongsub, et al.
Publicado: (2018)

A contact investigation after exposure to a child with disseminated tuberculosis mimicking inflammatory bowel disease
por: Kim, Dongsub, et al.
Publicado: (2018)

Development of a Modified Naturalistic Action Test for Korean Patients With Impaired Cognition
por: Jung, Mi Ae, et al.
Publicado: (2013)

Teicoplanin pharmacokinetics during albumin dialysis
por: Weiler, Stefan, et al.
Publicado: (2010)

Difference in the Prevalence of Elevated Blood Pressure and Hypertension by References in Korean Children and Adolescents
por: Kim, Jeong Yeon, et al.
Publicado: (2022)

DUOX2 Mutations Are Frequently Associated With Congenital Hypothyroidism in the Korean Population
por: Park, Kyoung-Jin, et al.
Publicado: (2016)

Dried Blood Spot Testing for Seven Steroids Using Liquid Chromatography-Tandem Mass Spectrometry With Reference Interval Determination in the Korean Population
por: Kim, Borahm, et al.
Publicado: (2015)

Understanding the Current Status of Korean Heart Transplantation Based on Initial KOTRY Report
por: Kim, In-Cheol, et al.
Publicado: (2017)

Therapeutic Drug Monitoring and Nephrotoxicity of Teicoplanin Therapy in Chinese Children: A Retrospective Study
por: Sun, Dan, et al.
Publicado: (2020)

The Multifaceted Clinical Characteristics of Congenital Cytomegalovirus Infection: From Pregnancy to Long-Term Outcomes
por: Kim, Yejin, et al.
Publicado: (2023)

Statement on healthcare system preparedness in response to COVID-19 Omicron subvariants BA.4 and BA.5 surge in Korea from the Korean Pediatric Society and Korean Society of Pediatric Infectious Diseases
por: Cho, Eun Young, et al.
Publicado: (2022)

Recommended immunization schedule for children and adolescents: Immunization Guideline (8th edition) released by the Korean Pediatric Society in 2015
por: Kim, Jong-Hyun, et al.
Publicado: (2016)

1326. Mupirocin Resistance in Staphylococcus aureus in Pediatric Patients for Ten Years
por: Park, Hwanhee, et al.
Publicado: (2022)

Association between nicotine dependency with occupational injury in Korean men
por: Jang, Sung Wook, et al.
Publicado: (2021)

A Novel Mutation (c.200T>C) in the NAGLU Gene of a Korean Patient with Mucopolysaccharidosis IIIB
por: Kim, Young-Eun, et al.
Publicado: (2013)

Normal stress difference–driven particle focusing in nanoparticle colloidal dispersion
por: Kim, Bookun, et al.
Publicado: (2019)

Development of the Korean Academy of Medical Sciences Guideline for Rating Physical Impairment
por: Lee, Kyeong-Seok, et al.
Publicado: (2009)

Tools for the Individualized Therapy of Teicoplanin for Neonates and Children
por: Ramos-Martín, V., et al.
Publicado: (2017)

Synthesis of Antiviral Perfluoroalkyl Derivatives of Teicoplanin and Vancomycin
por: Bereczki, Ilona, et al.
Publicado: (2020)

Teicoplanin: an alternative drug for the treatment of COVID-19?
por: Baron, Sophie Alexandra, et al.
Publicado: (2020)

Clinical outcomes of teicoplanin use in the OPAT setting
por: Dabrowski, Hannah, et al.
Publicado: (2020)

The First Dimeric Derivatives of the Glycopeptide Antibiotic Teicoplanin
por: Bereczki, Ilona, et al.
Publicado: (2022)

Incidence of teicoplanin adverse drug reactions among patients with vancomycin-associated adverse drug reactions and its risk factors
por: Kim, Byung-Keun, et al.
Publicado: (2020)

Korean Academy of Medical Sciences Pediatric Impairment Guideline for Brain Lesion
por: Jung, Han-Young, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_qbaocpci8r0r5s98jr71k12g8t